Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Other hematologic neoplasm 1Myeloid 1

Conditions

Breast Neoplasms 529Neoplasms 494Carcinoma, Non-Small-Cell Lung 404Prostatic Neoplasms 309Colorectal Neoplasms 293Lung Neoplasms 272Neoplasm Metastasis 225Leukemia, Myeloid, Acute 214Ovarian Neoplasms 197Pancreatic Neoplasms 188Multiple Myeloma 181Squamous Cell Carcinoma of Head and Neck 141Recurrence 139Stomach Neoplasms 137Brain Neoplasms 131Melanoma 129Carcinoma, Hepatocellular 128Endometrial Neoplasms 118Triple Negative Breast Neoplasms 116Glioblastoma 112Precursor Cell Lymphoblastic Leukemia-Lymphoma 108Hematologic Neoplasms 99Head and Neck Neoplasms 99Urinary Bladder Neoplasms 97Carcinoma, Renal Cell 97Lymphoma 95Glioma 90Sarcoma 89Esophageal Neoplasms 87Lymphoma, Large B-Cell, Diffuse 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Preleukemia × 90 days × Clear all
NCT07216443 2026-04-15

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Orca Biosystems, Inc.

Phase 2 Recruiting
80 enrolled
MyeloidOther hematologic neoplasmOther neoplasm

Acute Disease, Bone Marrow Diseases, Disease, Graft vs Host Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Precancerous Conditions, Preleukemia, Syndrome, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Disease Attributes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡